Free Trial

Rani Therapeutics (RANI) Earnings Date, Estimates & Call Transcripts

Rani Therapeutics logo
$1.17 +0.02 (+1.74%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.25 +0.08 (+7.18%)
As of 04/17/2025 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rani Therapeutics Earnings Summary

Upcoming
Earnings Date
May. 5Before Market OpensEstimated
Consensus EPS
(Mar. 31)
-$0.24
Actual EPS
(Mar. 31)
-$0.27 Missed By -$0.03
Actual Revenue
(Mar. 31)
$1.03M

Rani Therapeutics posted Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.27, which missed analysts' consensus estimates of -$0.24 by $0.03. Quarterly revenue was reported to be $1.03 million. With a trailing EPS of -$1.06, Rani Therapeutics' earnings are expected to grow next year, from ($1.01) to ($0.84) per share.

Q4 2024 Earnings Resources

RANI Upcoming Earnings

Rani Therapeutics' Q1 2025 earnings is scheduled for Monday, May 5, 2025

Get Rani Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rani Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RANI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Rani Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.01) EPS
Next Year EPS Consensus Estimate
($0.84) EPS

Rani Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2025
(Estimated)
--------
3/31/2025Q4 2024-$0.24-$0.27 -$0.03-$0.27-$1.03M
8/6/2024--$0.29-$0.26+$0.03-$0.26--
5/6/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29--
3/20/2024Q4 2023-$0.31-$0.27+$0.04-$0.27--
11/8/2023Q3 2023-$0.47-$0.36+$0.11-$0.36--
8/11/2023Q2 2023-$0.40-$0.37+$0.03-$0.37--
5/10/2023Q1 2023-$0.47-$0.33+$0.14-$0.33--

Rani Therapeutics Earnings - Frequently Asked Questions

Rani Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on RANI's earnings history.

In the previous quarter, Rani Therapeutics (NASDAQ:RANI) missed the analysts' consensus estimate of ($0.24) by $0.03 with a reported earnings per share (EPS) of ($0.27). Learn more on analysts' earnings estimate vs. RANI's actual earnings.

The conference call for Rani Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Rani Therapeutics's latest earnings report can be read online.
Read Transcript

Rani Therapeutics (NASDAQ:RANI) has a recorded annual revenue of $1.03 million.

Rani Therapeutics (NASDAQ:RANI) has a recorded net income of -$33.97 million. RANI has generated -$1.06 earnings per share over the last four quarters.

Rani Therapeutics's earnings are expected to grow from ($1.01) per share to ($0.84) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RANI) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners